Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
New bioengineering research reported from University of Texas, Department of Radiology
September 16th, 2008
Current study results from the report, 'A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo,' have been published. According to a study from the United States, "Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection in the target tissue and the longevity of gene expression." "Thus, there is increasing interest in the development of non-invasive in vivo reporter techniques to assay gene expression. We recently demonstrated the ability to detect beta-galactosidase activity in stably...
Source: Cancer Weekly (2008-09-16)
|
